Meningitis in diabetic patients.
Muli J, Seckova S, Sladeckova V, Steno J, Adamcova J, Rabarova L, Takacova M, Polonova J, Dudasova T, Pauerova K, Namulanda V, Okoth V, Juma O, Diana E, Johnson M, Deadline J, Bartkovjak M, Kolenova A, Taziarova M, Benca J, Njambi Z.
Journal Article
2007; 28(Suppl 3): 28-29
PubMed PMID: 18030274
Citation
Keywords:
Anti-Bacterial Agents:therapeutic use, Cefotaxime:therapeutic use, Cohort Studies, Community-Acquired Infections:microbiology, Diabetes Complications:immunology, Diabetes Mellitus:immunology, Humans, Meningitis, Bacterial:etiology, Outcome Assessment (Hea.
: Community acquired bacterial (CBM) meningitis in diabetic patients was analyzed for risk factors and outcome in a cohort of 201 cases of meningitis within last 17 years: 15 patients with diabetes mellitus and meningitis were identified and compared for etiology and mortality as well as for neurologic sequellae with all CBM cases....
Citation
Muli J, Seckova S, Sladeckova V, Steno J, Adamcova J, Rabarova L, Takacova M, Polonova J, Dudasova T, Pauerova K, Namulanda V, Okoth V, Juma O, Diana E, Johnson M, Deadline J, Bartkovjak M, Kolenova A, Taziarova M, Benca J, Njambi Z. Meningitis in diabetic patients. Neuro Endocrinol Lett. 2007 Nov; 28(Suppl 3): 28-29